These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

945 related items for PubMed ID: 30616780

  • 1. Chest radiography or chest CT plus head and neck CT versus 18F-FDG PET/CT for detection of distant metastasis and synchronous cancer in patients with head and neck cancer.
    Kim Y, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Oral Oncol; 2019 Jan; 88():109-114. PubMed ID: 30616780
    [Abstract] [Full Text] [Related]

  • 2. Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer.
    Rohde M, Nielsen AL, Johansen J, Sørensen JA, Nguyen N, Diaz A, Nielsen MK, Asmussen JT, Christiansen JM, Gerke O, Thomassen A, Alavi A, Høilund-Carlsen PF, Godballe C.
    J Nucl Med; 2017 Dec; 58(12):1919-1924. PubMed ID: 28572489
    [Abstract] [Full Text] [Related]

  • 3. Clinical utility of 18F-FDG PET/CT for patients with recurrent head and neck squamous cell carcinoma.
    Ha SC, Roh JL, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY.
    Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
    [Abstract] [Full Text] [Related]

  • 4. FDG-PET and detection of distant metastases and simultaneous tumors in head and neck squamous cell carcinoma: a comparison with chest radiography and chest CT.
    Krabbe CA, Pruim J, van der Laan BF, Rödiger LA, Roodenburg JL.
    Oral Oncol; 2009 Mar; 45(3):234-40. PubMed ID: 18715818
    [Abstract] [Full Text] [Related]

  • 5. Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis.
    Noij DP, Martens RM, Zwezerijnen B, Koopman T, de Bree R, Hoekstra OS, de Graaf P, Castelijns JA.
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [Abstract] [Full Text] [Related]

  • 6. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma.
    Haerle SK, Schmid DT, Ahmad N, Hany TF, Stoeckli SJ.
    Oral Oncol; 2011 Jul; 47(7):653-9. PubMed ID: 21658990
    [Abstract] [Full Text] [Related]

  • 7. PET/CT prior to salvage surgery in recurrent head and neck squamous cell carcinoma.
    Nøhr A, Gram SB, Charabi B, Tvedskov JF, Wessel I, Friborg J, Håkansson K, von Buchwald C, Fischer BM, Rasmussen JH.
    Eur Arch Otorhinolaryngol; 2019 Oct; 276(10):2895-2902. PubMed ID: 31297609
    [Abstract] [Full Text] [Related]

  • 8. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL, Rajendran J, Yueh B, Coltrera M, Anzai Y, Krohn K, Eary J.
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [Abstract] [Full Text] [Related]

  • 9. Comparison of 18F-FDG PET/CT scan and 99mTc-MDP bone scintigraphy in detecting bone metastasis in head and neck tumors.
    Al-Bulushi NK, Abouzied ME.
    Nucl Med Commun; 2016 Jun; 37(6):583-8. PubMed ID: 26813992
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic performance of 18 fluorodesoxyglucose positron emission/computed tomography and magnetic resonance imaging in detecting T1-T2 head and neck squamous cell carcinoma.
    Chaput A, Robin P, Podeur F, Ollivier M, Keromnes N, Tissot V, Nonent M, Salaün PY, Rousset J, Abgral R.
    Laryngoscope; 2018 Feb; 128(2):378-385. PubMed ID: 28600822
    [Abstract] [Full Text] [Related]

  • 11. Use of Diffusion-Weighted Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Combined With Computed Tomography in the Response Assessment for (Chemo)radiotherapy in Head and Neck Squamous Cell Carcinoma.
    Noij DP, Martens RM, Koopman T, Hoekstra OS, Comans EFI, Zwezerijnen B, de Bree R, de Graaf P, Castelijns JA.
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [Abstract] [Full Text] [Related]

  • 12. Screening for distant metastases in head and neck cancer patients by chest CT or whole body FDG-PET: a prospective multicenter trial.
    Senft A, de Bree R, Hoekstra OS, Kuik DJ, Golding RP, Oyen WJ, Pruim J, van den Hoogen FJ, Roodenburg JL, Leemans CR.
    Radiother Oncol; 2008 May; 87(2):221-9. PubMed ID: 18410977
    [Abstract] [Full Text] [Related]

  • 13. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
    Basu D, Siegel BA, McDonald DJ, Nussenbaum B.
    Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
    [Abstract] [Full Text] [Related]

  • 14. Positron emission tomography in the evaluation of synchronous lung lesions in patients with untreated head and neck cancer.
    Wax MK, Myers LL, Gabalski EC, Husain S, Gona JM, Nabi H.
    Arch Otolaryngol Head Neck Surg; 2002 Jun; 128(6):703-7. PubMed ID: 12049568
    [Abstract] [Full Text] [Related]

  • 15. Comparison of 18F-FDG PET/MRI, MRI, and 18F-FDG PET/CT for the detection of synchronous cancers and distant metastases in patients with oropharyngeal and hypopharyngeal squamous cell carcinoma.
    Yeh CH, Chan SC, Lin CY, Yen TC, Chang JT, Ko SF, Fan KH, Wang HM, Liao CT, Ng SH.
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):94-104. PubMed ID: 31606831
    [Abstract] [Full Text] [Related]

  • 16. 18F-FDG PET/CT for detecting distant metastases in patients with recurrent head and neck squamous cell carcinoma.
    Yi JS, Kim JS, Lee JH, Choi SH, Nam SY, Kim SY, Roh JL.
    J Surg Oncol; 2012 Nov; 106(6):708-12. PubMed ID: 22674652
    [Abstract] [Full Text] [Related]

  • 17. Chest CT and whole-body 18F-FDG PET are cost-effective in screening for distant metastases in head and neck cancer patients.
    Uyl-de Groot CA, Senft A, de Bree R, Leemans CR, Hoekstra OS.
    J Nucl Med; 2010 Feb; 51(2):176-82. PubMed ID: 20124045
    [Abstract] [Full Text] [Related]

  • 18. 18F-FDG PET/CT surveillance for the detection of recurrence in patients with head and neck cancer.
    Kim SA, Roh JL, Kim JS, Lee JH, Lee SH, Choi SH, Nam SY, Kim SY.
    Eur J Cancer; 2017 Feb; 72():62-70. PubMed ID: 28027517
    [Abstract] [Full Text] [Related]

  • 19. Screening for distant metastases in patients with head and neck cancer: is there a role for (18)FDG-PET?
    Brouwer J, Senft A, de Bree R, Comans EF, Golding RP, Castelijns JA, Hoekstra OS, Leemans CR.
    Oral Oncol; 2006 Mar; 42(3):275-80. PubMed ID: 16266820
    [Abstract] [Full Text] [Related]

  • 20. The role of (18)F-FDG PET/CT in initial staging of patients with locally advanced breast carcinoma with an emphasis on M staging.
    Mittal BR, Manohar K, Kashyap R, Bhattacharya A, Singh B, Singh G.
    Hell J Nucl Med; 2011 Mar; 14(2):135-9. PubMed ID: 21761015
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.